Aurobindo in-licenced chemotherapy induced neutropenia drug Ryzneuta gets USFDA nod, sends scrip soaring to 52-week high
India Business News: Aurobindo Pharma has received approval from the US Food & Drug Administration (USFDA) for its long-acting Granulocyte colony-stimulating factor (G-CSF
Source: indiatimes.com